Moreover, P53 signaling pathway, metabolism-related pathways, DNA replication pathway, and DDR-related pathways, such as BER, MMR, NER, and HR, were also notably enriched in STAD patients with FAT family gene mutations (ES > 0 and q < 0.05). This evidence concerns the gene TP53 and gastric adenocarcinoma.